Based on the recent market action its hard to make a case to buy an up opening like we are walking into today.  Greece is still acting as an overhang but the real issue might be what’s going on in China, will it have any spillover effect is the question.

Biotechs continue to standout while most other sectors continue to struggle.  For the first time in a while we have more stocks down 25% for the quarter than up 25% for the quarter (Stockbee Indicator) all this while the indices are a stone throw away from all time highs.

We have seen a spike in stocks making new 1 month lows and 3 month lows.  These type of spikes have led to short term bounces in the past except in October when the spikes led to more downside.

I hate to use twitter or stocktwits to gauge sentiment because you really don’t know what a person is doing.  Their stream might give you a certain impression that is far from reality.  However, a great deal of people have been bearish for a long time and they still are, from a contrarian standpoint that is bullish. On the flip side I think that many have grown to be complacent because of the way the market has rebounded ferociously every time it looked and felt like it was going to break down.  This has trained people to look the other way and or ignore their stops in hope that the market will bail them out as it has over the last few years, this is when it gets dicey.

Summer is here, slow down.  Keep a close eye on biotechs; $XBI, $IBB, for clues, a breakdown in that sector could weigh on the market, but so far they continue to be strong like bull.

This information is issued solely for informational and educational purposes and does not constitute an offer to sell or a solicitation of an offer to buy securities. None of the information contained in this blog constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. From time to time, the content creator or its affiliates may hold positions or other interests in securities mentioned in this blog. The stocks presented are not to be considered a recommendation to buy any stock. This material does not take into account your particular investment objectives. Investors should consult their own financial or investment adviser before trading or acting upon any information provided. Past performance is not indicative of future results.